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Background
Cryopyrin-associated periodic syndromes (CAPS) are the
rare hereditary autoinflammatory diseases. CAPS include
three similar conditions are distinguished which lie along
a phenotypical continuum with increasing levels of sever-
ity: familial cold autoinflammatory syndrome (FCAS),
Muckle-Wells syndrome (MWS) and CINCA/NOMID.
Distinguishing features include cutaneous, neurological,
ophthalmologic and rheumatologic manifestations. CAPS
results from a gain-of-function mutation of the NLRP3
gene (CIAS1) coding for cryopyrin. There is no produc-
tion of autoantibodies, but interleukin-1 plays an impor-
tant role and acute-phase reactants show abnormalities.
Our aim was to report on two cases of CAPS that are
considered to be rare entities.
Case reports
In our clinic we observed two cases: MWS and CINCA/
NOMID.
The case 1
A 16-year-old Caucasian female had had symptoms begin-
ning at the age of one year, including fever, recurrent urti-
caria, conjunctivitis, localized abdominal pain, neutrophil
leukocytosis, since the 12 years periodic arthritis, which
lasted a few days, otitis, uveitis. The laboratory findings
included an ESR of up to 62 mm/h, anemia, neutrophil
leukocytosis, C-reactive proteine rise, ANA and RF were
negative. 15 years after the symptoms began, sensorineural
deafness was diagnosed and MWS was suspected. A
genetic analysis on the patient showed a new mutation
(heterozygous) in the CIAS1 gene (c.1049C>T), thus
confirming the diagnosis. The patient was treated with
antibiotics and methotrexate without any response.
The case 2
An 10-month-old boy complained of daily fever, recur-
rent since the first days of a life, blepharitis and conjunc-
tivitis, neuroretinitis, panuveitis, sensorineural deafness,
arthralgia, mixed hydrocephaly with the signs of cortex,
visual nerves and corpus collosum atrophy on brain MRI.
The laboratory findings included an ESR of up to 40
mm/h, anemia, neutrophil leukocytosis, C-reactive pro-
teine rise, ANA and RF were negative, Interleukin-1- 152
pg\ml (under 5,0). With these findings, CINCA syndrome
was suspected. A genetic analysis on the patient showed a
new mutation in the CIAS1 gene (G569R), thus confirm-
ing the diagnosis. The patient was treated with predni-
sone with a partial response. Since beginning treatment
with anti-interleukin-1(anakinra) up to 4mg/kg/d pts has
had excellent control of his disorder.
Conclusions
We report two rare cases of CAPS. These pts presented
fever, cutaneous, neurological, ophthalmologic and rheu-
matologic manifestations, that dramatically improved
with anakinra in one of pts. Pts with CAPS need anti IL-
1 treatment for the successful in suppressing inflamma-
tion and reduction in the number and duration attacks.
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